FDA took 15 months to act on infant formula whistleblower complaint, audit says

The Food and Drug Administration (FDA) was dangerously slow to respond to multiple complaints about conditions at an Abbott Nutrition facility that contributed to a nationwide infant formula shortage in 2022, according to a government watchdog report. FDA did not have adequate — and in some cases completely lacked — policies and procedures to identify risks to infant...